Immunovant, Inc.·4

Jan 12, 5:03 PM ET

MIGAUSKY GEORGE V 4

4 · Immunovant, Inc. · Filed Jan 12, 2022

Insider Transaction Report

Form 4
Period: 2022-01-10
Transactions
  • Award

    Stock Option (right to buy)

    2022-01-10+71,492131,792 total
    Exercise: $7.94Exp: 2032-01-10Common Stock (71,492 underlying)
  • Award

    Common Stock

    2022-01-10+21,72688,926 total
Footnotes (3)
  • [F1]Represents the number of shares underlying restricted stock units awards ("RSUs").
  • [F2]The RSUs vest over a period of two years, in a series of eight successive equal installments from the date of the award, subject to the Reporting Person providing continuous service to the Issuer as of each such date.
  • [F3]Shares underlying the options vest over a period of two years, in a series of eight successive equal installments from the date of the award, subject to the Reporting Person providing continuous service to the Issuer as of each such date.

Documents

2 files
  • 4
    wf-form4_164202501508435.xmlPrimary

    FORM 4

  • EX-24

    POWER OF ATTORNEY FOR: GEORGE V. MIGAUSKY